Related Experiment Video
Updated: Aug 26, 2026
Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Tranexamic acid in primary CABG surgery: high vs low dose
G Armellin1, A Vinciguerra, R Bonato
1Department of Pharmacology and Anesthesiology Egidio Meneghetti, University of Padua, Padua, Italy. gabriarmellin@libero.it
Aim:
Prophylactic administration of tranexamic acid decreases bleeding and transfusions after cardiac procedures but it is still unclear what the best dose and the most appropriate timing to get the best results are.
Methods:
We enrolled 250 patients scheduled for elective, primary coronary revascularization. They were randomly divided into 2 groups. Group H received tranexamic 30 mg x kg(-1) soon after the induction of anaesthesia and a further same dose was added to the prime solution of cardiopulmonary bypass (CPB). Group L received tranexamic acid 15 mg x kg(-1) after systemic heparinization followed by an infusion of 1 mg x kg(-1) h(-1) till the end of the operation. Transfusions of bank blood products, bleeding in the postoperative period and coagulation profile were recorded.
Results:
We did not find any difference between the groups either with respect to transfusion requirements or with respect to blood loss.
Conclusion:
For elective, first time coronary artery bypass surgery, both dosages of tranexamic acid are equally effective. Theoretically, it seems safer to administer it when patients are protected from thrombus formation by full heparinization.
